Medroxyprogesterone Acetate

Specifications

71-58-9CAS Number

200-757-9EC Number

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetateIUPAC Name

C24H34O4Chemical Formula

386.5 g/molMolecular Weight

Medroxyprogesterone acetate; 71-58-9; Medroxyprogesterone 17-acetate; Provera; Depo-Provera; Metigestrona; Farlutin; Clinovir; Gestapuran; Lutopolar; Perlutex; Oragest; Veramix; Amen; Methylacetoxyprogesterone; Medroxyacetate progesterone; Progestalfa; Clinofem; Nadigest; Nidaxin; Prodasone; Progevera; Proverone; Repromix; Sirprogen; Hysron; Depo-clinovir; Depo-progestin; Depot-medroxyprogesterone acetate; NSC-26386; Repromap; Provera dosepak; Depo-Progevera; 6-alpha-Methyl-17-alpha-acetoxyprogesterone; Cycrin; MAP (steroid); Depo-Subq Provera 104; 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate; Aragest; Farlutal; 17alpha-Hydroxy-6alpha-methylprogesterone acetate; 6alpha-Methyl-17alpha-hydroxyprogesterone acetate; Depo-subq provera; Depot medroxyprogesterone acetate; 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate; 17-Acetoxy-6alpha-methylprogesterone; 6alpha-Methyl-17-acetoxyprogesterone; 6alpha-Methyl-17-acetoxy progesterone; Depo-Medroxyprogesterone acetate; Nogest; DTXSID0025527; C2QI4IOI2G; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-; NSC-21171; 17-Acetoxy-6-alpha-methylprogesterone; U 8839; 6-alpha-Methyl-17-acetoxy progesterone; (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione; 17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate; Medroxyprogesteroni acetas; Progesterone, 17-hydroxy-6alpha-methyl-, acetate; 17-alpha-Hydroxy-6-alpha-methylprogesterone acetate; TV-46046; 17-alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione; 6-alpha-Methyl-17-alpha-acetoxypregn-4-ene-3,20-dione; Progesterone, 17-alpha-hydroxy-6-alpha-methyl-, acetate; g-Farlutal; Medroxyprogesterone 17 Acetate; (6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate; CHEBI:6716; DTXCID905527; 17alpha-Acetoxy-6alpha-methylprogesterone; 6-alpha-Methyl-4-pregnene-3,20-dion-17-alpha-ol acetate; 17-alpha-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione acetate; NSC21171; NSC26386; (6-alpha)-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-; Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate; Metipregnone; PREMPRO COMPONENT MEDROXYPROGESTERONE ACETATE; 6alpha-Methyl-3,20-dioxopregn-4-en-17-yl acetate; PREMPHASE COMPONENT MEDROXYPROGESTERONE ACETATE; Sodelut G; Ciclotal; Climanor; DepoProvera; Sayana press; Depo Provera; Nadigest (vet); Nidaxin (vet); Farlutal 100; Farlutal 200; Farlutal 250; Farlutal 500; Depo-provera oncology; RefChem:810842; 6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate; Depo Medroxyprogesterone Acetate; Depot-Medroxyprogestereone Acetate; 6-Alpha-methyl-17alpha-acetoxyprogesterone; Medroxyprogesterone Acetate Injectable Suspension; 6 alpha Methyl 17alpha hydroxyprogesterone Acetate; 17-(Acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione; (6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione; (6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione; (1S,2R,8S,10R,11S,14R,15S)-14-acetyl-2,8,15-trimethyl-5-oxotetracyclo(8.7.0.02,7.011,15)heptadec-6-en-14-yl acetate; 200-757-9; NSC-27408; Deporone; Depo-Promone; Depcorlutin; Supprestral; Promone-E; Medroxyprogesterone-17-acetate; Medroxyprogesteroneacetate; DP150; Ralovera; Depo-Ralovera; MFCD00010483; Medroxyprogesterone acetate (Standard); MLS000069442; MLS001148217; Indivina; Medroxy Progesterone 17-Acetate; ONCO-Provera; Depo-Prodasone; Depomedroxyprogesterone acetate; Aragest 5; Med-Pro; 17alpha-acetoxy-6alpha-methylpregn-4-ene-3,20-dione; (6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate; [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate; 6alpha-Methyl-17alpha-acetoxyprogesterone; Medrosterona; Cykrina; Depocon; Mepastat; Meprate; SMR000059125; Sumiferm; Suprestral; Veraplex; Dugen; Perlutex Leo; Depo-Map; MPA-beta; MPA Hexal; MPA-Noury; MPA GYM; CAS-71-58-9; CCRIS 371; 17.alpha.-Acetoxy-6.alpha.-methylprogesterone; Medroxyprogesterone acetate [JAN]; EINECS 200-757-9; UNII-C2QI4IOI2G; NSC 21171; Depo-Provera Contraceptive; (6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-; 17.alpha.-Hydroxy-6-.alpha.-methylprogesterone acetate; Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-, acetate; BRN 2066112; Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, (6.alpha.)-; AI3-60127; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6.alpha.)-; 17-Acetoxy-6.alpha.-methylprogesterone; 6.alpha.-Methyl-17-acetoxyprogesterone; NCGC00094713-01; 17alpha-Hydroxy-6-alpha-methylprogesterone acetate; CBP-1011; Provera (TN); Depo-provera (TN); 6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione; Medroxyprogesterone acetate [USP:JAN]; 17alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione; Medroxyprogesterone acetate [Progestins]; 6.alpha.-Methyl-17.alpha.-acetoxyprogesterone; Medroxyprogesone acetate; (6-alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate; 6alpha-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-; CPD000653524; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6a)-; Opera_ID_1110; medroxyprogesterone-acetate; 17.alpha.-Hydroxy-6.alpha.-methylprogesterone acetate; 6.alpha.-Methyl-17.alpha.-hydroxyprogesterone acetate; CHEMBL717; SCHEMBL4276; 6.alpha.-Methyl-17.alpha.-acetoxypregn-4-ene-3,20-dione; 17.alpha.-Acetoxy-6-.alpha.-methylpregn-4-ene-3,20-dione; 4-08-00-02212 (Beilstein Handbook Reference); 6.alpha.-Methyl-4-pregnene-3,20-dion-17.alpha.-ol acetate; MLS002207115; Medroxyprogesterone acetate RS; 17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione acetate; Medroxyprogesterone acetate CRS; Depo-subq provera 104 (TN); orb1309193; orb3139831; HY-B0469R; MSK2210; HMS2233O07; HMS2235E05; HMS3259O14; HMS3884B10; 17?-Acetoxy-6?-methylprogesterone; HY-B0469; Tox21_111319; Tox21_200141; BDBM50067678; EBC-26889; MSK2210-100A; s2567; AKOS015894870; MSK2210-1000A; Tox21_111319_1; AC-2174; CCG-264965; DB00603; FM25036; NC00574; Medroxyprogesterone acetate (JP18/USP); MRF-0000023; Medroxyprogesterone 17-acetate(Standard); NCGC00022037-03; NCGC00022037-04; NCGC00022037-05; NCGC00022037-07; NCGC00022037-08; NCGC00257695-01; NCGC00263480-01; (1R,3aS,3bR,5S,9aR,9bS,11aS)-1-acetyl-5,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate; AS-13981; MEDROXYPROGESTERONE ACETATE [IARC]; SMR000653524; SY077009; MEDROXYPROGESTERONE ACETATE [MART.]; MEDROXYPROGESTERONE ACETATE [VANDF]; MEDROXYPROGESTERONE 17-ACETATE [MI]; MEDROXYPROGESTERONE ACETATE [USP-RS]; MEDROXYPROGESTERONE ACETATE [WHO-DD]; MEDROXYPROGESTERONE ACETATE [WHO-IP]; CS-0694837; M1613; NS00006415; C08150; C76275; D00951; 17?-Acetoxy-6?-methylpregn-4-ene-3,20-dione; AB00384270-14; AB00384270_15; EN300-7480751; Medroxyprogesterone 17-acetate, >=97% (HPLC); MEDROXYPROGESTERONE ACETATE [ORANGE BOOK]; MEDROXYPROGESTERONI ACETAS [WHO-IP LATIN]; F787593; MEDROXYPROGESTERONE ACETATE [EP MONOGRAPH]; MEDROXYPROGESTERONE ACETATE [USP MONOGRAPH]; MEGESTROL ACETATE IMPURITY A [EP IMPURITY]; 17|_-Acetoxy-6|_-methylpregn-4-ene-3,20-dione; LUNELLE COMPONENT MEDROXYPROGESTERONE ACETATE; Q2823834; 6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-; Medroxyprogesterone acetate for peak identification CRS; Medroxyprogesterone acetate for system suitability CRS; (6?)-17-(Acetyloxy)-6-methyl-pregn-4-ene-3,20-dione; Medroxyprogesterone-17-acetate 100 |Ig/mL in Acetonitrile; Medroxyprogesterone acetate Solution in Acetonitrile, 1000ug/mL; Medroxyprogesterone acetate Solution in Acetonitrile, 100ug/mL; Medroxyprogesterone Acetate; Megestrol Acetate EP Impurity A; Medroxyprogesterone-17-acetate 100 microg/mL in Acetonitrile; Medroxyprogesterone 17-acetate, VETRANAL(TM), analytical standard; Medroxyprogesterone Acetate Working Standard (Secondary Reference Standard); Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard; Medroxyprogesterone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material; Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard; 1301724-98-0; Medroxyprogesterone 17-acetate; 17|A-Acetoxy-6|A-methylprogesterone; 17|A-Hydroxy-6|A-methyl-4-pregnene-3,20-dione 17-acetate; 6|A-Methyl-17|A-acetoxyprogesterone; 6|A-Methyl-17|A-hydroxyprogesterone acetate; Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard; Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyms